Expert Ratings for Freeport-McMoRan
Analysts have provided the following ratings for Freeport-McMoRan (NYSE:FCX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
What 10 Analyst Ratings Have To Say About Nutanix
Within the last quarter, Nutanix (NASDAQ:NTNX) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Analyst Ratings for Vericel
Over the past 3 months, 5 analysts have published their opinion on Vericel (NASDAQ:VCEL) stock. These analysts are…
Analyst Expectations for Mesoblast’s Future
Analysts have provided the following ratings for Mesoblast (NASDAQ:MESO) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Analyst Expectations for European Wax Center’s Future
Over the past 3 months, 5 analysts have published their opinion on European Wax Center (NASDAQ:EWCZ) stock. These…
Expert Ratings for FirstEnergy
Over the past 3 months, 6 analysts have published their opinion on FirstEnergy (NYSE:FE) stock. These analysts are…
Why FedEx Stock Is On The Move Thursday
FedEx Corp (NYSE: FDX) shares are trading higher Thursday after the company reported mixed financial results and raised its earnings outlook.
U.S. Food And Drug Administration Approves Orphan Drug Designation For Immix Biopharma NXC-201 As A Treatment For Amyloid Light Chain Amyloidosis
FDA Orphan Drug Designation ("ODD") qualifies one-time treatment NXC-201 for:
7 years of U.S. market exclusivity after approval
Tax credits for qualified clinical testing
Waiver of the Prescription Drug
Cannabis Market Competition Heats Up In Florida: Cresco Expands Portfolio As Legalization Looms
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) is expanding its cannabis brand portfolio in the Sunshine State to include the FloraCal and Cresco brands.
VinFast Aims To Ship EVs To Europe By 2023 End: Report
Vietnamese electric vehicle manufacturer VinFast Auto Ltd (NASDAQ: VFS) reportedly plans to ship its first batch of EVs to Europe this year after regulatory approval.